SCENESSE FDA approval date

The FDA approved SCENESSE on 8 Oct 2019.

FDA approval date
8 Oct 2019

Drug identity has not yet been verified against registry records

Also recorded as AFAMELANOTIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2019-10-08DaySCENESSEFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA210797", "applicant_as_listed_by_fda": "CLIVUNEL INC", "brand_names": ["SCENESSE"], "active_ingredients": ["AFAMELANOTIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20191008", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026